Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Multiple Sclerosis

  Free Subscription


25.01.2010

1 BMJ
1 Eur Neurol
1 J Neurol
1 Lancet Neurol
12 Mult Scler
4 N Engl J Med
2 Neurology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. WATTS G
    New partnership pumps pound 1m into stem cell research for multiple sclerosis.
    BMJ. 2010;340:c292.
    PubMed     Text format     Related articles   


    Eur Neurol

  2. PUTZKI N , Yaldizli O, Buhler R, Schwegler G, et al
    Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland.
    Eur Neurol. 2010;63:101-106.
    PubMed     Text format     Related articles    Abstract available


    J Neurol

  3. SIMMONS RD , Tribe KL, McDonald EA
    Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Lancet Neurol

  4. YEH EA , Weinstock-Guttman B
    Multiple sclerosis: predicting risk and delaying progression.
    Lancet Neurol. 2010;9:7-9.
    PubMed     Text format     Related articles   


    Mult Scler

  5. SWANTON J , Fernando K, Dalton C, Miszkiel K, et al
    Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  6. SINCLAIR V , Shepard G
    Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  7. PAPADOPOULOS K , Tozer DJ, Fisniku L, Altmann DR, et al
    T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  8. WINSEN LM , Polman CH, Dijkstra CD, Tilders FJ, et al
    Suppressive effect of glucocorticoids on TNF-{alpha} production is associated with their clinical effect in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  9. VOGT MH , Ten Kate J, Drent RJ, Polman CH, et al
    Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  10. MESAROS S , Rocca M, Sormani M, Valsasina P, et al
    Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  11. SOMER E , Golan D, Dishon S, Cuzin-Disegni L, et al
    Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  12. MAGHZI A , Ghazavi H, Ahsan M, Etemadifar M, et al
    Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  13. FREEDMAN MS , Bar-Or A, Atkins HL, Karussis D, et al
    The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  14. WINSEN LM , Kragt JJ, Hoogervorst EL, Polman CH, et al
    Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  15. SALZER J , Svenningsson A, Sundstrom P
    Neurofilament light as a prognostic marker in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  16. REUB R , Schreiber V, Klein A, Infante-Duarte C, et al
    No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing-remitting multiple sclerosis patients.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available


    N Engl J Med

  17. GIOVANNONI G , Comi G, Cook S, Rammohan K, et al
    A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis.
    N Engl J Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  18. CARROLL WM
    Oral Therapy for Multiple Sclerosis -- Sea Change or Incremental Step?
    N Engl J Med. 2010.
    PubMed     Text format     Related articles   

  19. COHEN JA , Barkhof F, Comi G, Hartung HP, et al
    Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis.
    N Engl J Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  20. KAPPOS L , Radue EW, O'Connor P, Polman C, et al
    A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis.
    N Engl J Med. 2010.
    PubMed     Text format     Related articles    Abstract available


    Neurology

  21. WEINSTOCK-GUTTMAN B , Ramanathan M, Hashmi K, Abdelrahman N, et al
    Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available

  22. CREE B , Waubant E
    Does race matter for multiple sclerosis?
    Neurology. 2010.
    PubMed     Text format     Related articles   


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.

   Design: